China, 22nd Oct 2026 – DEEPBLUE SMARTHOUSE, an established supplier of light-gauge steel building systems, has outlined its panelized approach for developers, contractors and institutional project teams seeking a coordinated method for low-rise construction. The project-based supply model brings together engineering support, factory-fabricated components, containerized delivery and installation guidance.

The system serves a range of applications, including multi-unit housing, hospitality developments, workforce accommodation, schools, clinics and other low-rise facilities. Each package is defined around the project’s design, location, technical requirements and agreed division of responsibilities.

Bringing Design and Manufacturing Together

Panelized construction moves repeatable framing activities into a factory environment, where building components are manufactured against approved production drawings. Wall panels, floor systems and roof components are then identified and packed for transport and assembly. Clear identification of each component is intended to help the site team follow the agreed assembly sequence and keep deliveries organized by project stage.

For developers managing repeated unit types or phased programs, this approach can support more consistent procurement and construction planning. For contractors, coordinated panels and installation information can reduce the amount of measuring, cutting and framing required on site.

DEEPBLUE works with project teams to review architectural drawings, assess panelization feasibility and coordinate structural openings and building interfaces. Depending on the agreed scope, engineering deliverables may include shop drawings, panel drawings, material schedules and coordination with the client’s architect and local consultants.

“Panelization works best when design, engineering and production are coordinated from the start,” said David Chen, CEO of DEEPBLUE SMARTHOUSE. “Each project begins with a review of the drawings so that the factory scope matches what the site team will need.”

Defining the Supply Scope Before Production

A central part of the DEEPBLUE approach is establishing what the factory will supply and what the local project team will deliver.

Packages can include light-gauge steel wall panels, floor joists, floor panels, roof trusses and roof panels. Sheathing, additional panel layers, technical documentation and installation support are included where specified in the project agreement.

Before production begins, project teams review the proposed specifications, drawings, supply boundaries and responsibilities. This coordination helps align manufacturing with site requirements and gives buyers a clearer basis for procurement and budgeting.

Coordinating Engineering, Logistics and Assembly

The delivery process begins with a review of the project location, building use, scale, available drawings and target schedule. Engineering development then considers the applicable design criteria and approval pathway.

Wind, seismic, fire, thermal, acoustic and corrosion requirements depend on the project’s location and intended use. Required local reviews and professional approvals are coordinated with the client’s appointed consultants unless otherwise agreed.

Following drawing approval and production release, components are fabricated using CNC light-gauge steel equipment and inspected against approved production information. Packing and container loading are planned around the agreed shipment and assembly sequence.

Site installation is typically carried out by the client’s local contractor using the issued drawings and guidance. Additional training or technical support can be defined in the supply agreement.

Supporting Early Project Assessment

DEEPBLUE invites developers, builders, architects and procurement teams to submit project briefs for feasibility and scope review. Initial information should include the project location, intended use, estimated unit count or floor area, design stage, target schedule and expected supply requirements.

Projects at an early stage can also be assessed using available concept information, with further engineering and commercial details developed as the design progresses.

“Early project briefs allow the engineering team to confirm scope and responsibilities before drawings are finalized,” Chen said. “The aim is for developers and contractors to have a clear basis for planning as a project moves from concept to site assembly.”

About DEEPBLUE SMARTHOUSE

Based in Ningbo, China, DEEPBLUE SMARTHOUSE provides light-gauge steel building solutions for residential, hospitality and other low-rise projects. Its services encompass design coordination, engineering, factory production, quality control and international delivery, with the supply scope tailored to each project.

For additional information about panelized wall systems and related industry developments, contact DEEPBLUE SMARTHOUSE. Inquiries regarding the company’s products, services, engineering support and installation guidance can be directed by email to pr@deepbluehome.com. 

Media Contact

Organization: DEEPBLUE SMARTHOUSE

Contact Person: David Chen

Website: https://www.deepbluehome.com/

Email: Send Email

Country: China

Release id: 50092

View source version on King Newswire:
DEEPBLUE SMARTHOUSE Highlights Panelized Building Systems for Low Rise Development Projects

Wyoming-based company offers simulated trading accounts with live market data, crypto-based payments and transparent, rule-based evaluation

Cheyenne, Wyoming, United States, 22nd Oct 2026 — TRIXAU INC, a U.S. trading evaluation company headquartered in Cheyenne, Wyoming, has announced the launch of its trading evaluation program. The program is built for traders who want to have their skills assessed against clear, published rules, without depositing trading capital.

Participants trade a simulated account priced with live market quotes for gold, major forex pairs and leading cryptocurrencies, including Bitcoin, Ethereum and Solana. Every evaluation follows the same set of published parameters: a profit target, a daily loss limit and a maximum drawdown. These rules are enforced automatically by the platform’s risk engine on every price tick, so all participants are measured by identical criteria.

The program is designed around the way crypto-native traders already work. Evaluation fees are paid in cryptocurrency, including BTC, ETH, USDT, TRX and SOL, and the simulated account is issued automatically once the transaction is confirmed on chain. Participants who complete the evaluation and pass identity verification (KYC) become eligible for performance-based rewards, paid in USDT.

TRIXAU positions itself clearly as an evaluation company, not a broker. The company does not accept deposits, does not hold client funds for trading and does not execute real-money trades on anyone’s behalf. All program accounts use demonstration capital, and program fees cover the evaluation service only.

“Many traders want an honest way to find out whether their strategy holds up under real market conditions and strict risk rules,” said Efosa Ojomo, CEO of TRIXAU INC. “Our goal is to make that process transparent: the same rules for everyone, live market data and clear terms.”

The program offers several evaluation sizes, so traders can choose the account that matches their experience and strategy. Full program terms, rules and policies are available on the company’s website.

About TRIXAU INC

TRIXAU INC is a U.S. trading evaluation company based in Cheyenne, Wyoming. The company provides simulated trading accounts with live market data for gold, forex and cryptocurrencies, and evaluates trader performance against transparent, published rules. TRIXAU is not a broker-dealer, futures commission merchant or investment adviser.

Disclaimer: All evaluation accounts are simulated accounts with demonstration capital. Simulated performance does not guarantee future results. This press release is for informational purposes only and does not constitute investment advice.

Media Contact

Organization: TRIXAU INC

Contact Person: Efosa Ojomo

Website: https://trixau.com

Email: Send Email

Contact Number: +14055920144

Address: 1611 E 19th St

Address 2: Cheyenne, WY 82001

City: Cheyenne

State: Wyoming

Country: United States

Release id: 50090

View source version on King Newswire:
TRIXAU INC Launches Trading Evaluation Program for Crypto, Gold and Forex Traders in the U.S.

Volunteers from the Church of Scientology, Youth for Human Rights and Fundación MEJORA distribute educational materials on the Universal Declaration of Human Rights as Spain’s capital faces renewed debate over housing, civic participation and fundamental freedoms.

Brussels, Belgium, 22nd Oct 2026 — Volunteers associated with the Church of Scientology of Madrid, Youth for Human Rights and Fundación MEJORA, a Spanish foundation holding Special Consultative Status with the United Nations Economic and Social Council (ECOSOC), have been taking human rights education directly to the streets of the Spanish capital, distributing informational booklets designed to help residents and visitors better understand the 30 articles of the United Nations Universal Declaration of Human Rights.

The initiative forms part of an international educational programme supported by the Church of Scientology, which uses printed materials, audiovisual resources and community outreach to explain fundamental rights in accessible language.

The activity comes at a particularly relevant moment for Madrid, where public debate over housing, evictions and social protections has intensified following weeks of demonstrations and an ongoing protest encampment in Puerta del Sol, one of the city’s best-known public squares.

Although the human rights education initiative is independent of the housing protests, both are taking place against a backdrop of heightened public attention to fundamental rights, civic participation and the responsibilities of democratic institutions.

Bringing the Universal Declaration into Everyday Life

The volunteers are distributing What Are Human Rights?, an educational booklet presenting the 30 articles of the Universal Declaration of Human Rights, adopted by the United Nations General Assembly on 10 December 1948.

The publication explains rights such as equality before the law, freedom of expression, freedom of thought and religion, peaceful assembly, education, and access to an adequate standard of living.

Rather than focusing on a particular political issue, the educational campaign seeks to improve general awareness of the principles contained in the Declaration and their relevance to everyday situations.

The programme is internationally led by Youth for Human Rights International and United for Human Rights, two educational initiatives supported by the Church of Scientology that provide resources for schools, community organisations, volunteers and individuals interested in human rights education.

Their materials include printed booklets, teaching guides, the documentary The Story of Human Rights, and a series of 30 short public service announcements illustrating individual articles of the Declaration through situations intended to be understandable across different cultures and age groups.

The emphasis on accessible educational materials reflects a broader challenge in human rights education: making internationally recognised principles understandable outside specialist legal and institutional settings.

Madrid’s Housing Protests Bring Social Rights into Focus

The distribution campaign coincides with an unusually visible debate over housing rights in Spain.

Since 26 September, demonstrators have maintained an encampment in Madrid’s Puerta del Sol, a central square known internationally for its role in major civic mobilisations, including Spain’s 2011 protest movement.

The protest has drawn attention to rising housing costs, access to affordable accommodation, eviction procedures and the responsibilities of public authorities. It has also prompted political and legal debate over the continued presence of demonstrators in one of Madrid’s principal public spaces.

These developments provide a contemporary illustration of several principles contained in the Universal Declaration.

Article 25 recognises the right of everyone to a standard of living adequate for their health and well-being, including housing, food, clothing, medical care and necessary social services.

Articles 19 and 20 address freedom of expression and peaceful assembly, while Article 1 establishes the principle that all human beings are born free and equal in dignity and rights.

The Declaration itself is not a binding international treaty, but its principles have influenced subsequent international human rights agreements and constitutional frameworks, including those developed across Europe.

The Scientology-supported educational campaign has as its main purpose to make the underlying human rights principles more widely understood, regardless of individual political positions.

Human Rights Education and European Civic Values

Across Europe, the protection of fundamental rights is embedded in institutions and legal frameworks such as the European Convention on Human Rights and the European Union’s Charter of Fundamental Rights.

While these instruments differ in scope and legal application, they share principles with the Universal Declaration, particularly regarding human dignity, equality, fundamental freedoms and protection against discrimination.

For civil society organisations engaged in public education, explaining these principles in accessible terms represents one way of contributing to informed civic participation.

Ivan Arjona, representative of the Church of Scientology to the European Union, OSCE, Council of Europe and United Nations, connected the Madrid initiative with the wider European commitment to human rights.

“Europe’s commitment to human dignity, fundamental freedoms and the rule of law cannot depend solely on institutions or legal texts. It also depends on citizens knowing their rights and respecting those of others. At times of intense public debate, human rights education helps provide a common foundation for civic participation, peaceful disagreement and mutual respect. Making these principles understandable and accessible is a practical contribution that volunteers can make to democratic life.”

The Madrid campaign follows this educational approach by placing information directly in the hands of members of the public, rather than limiting awareness activities to conferences, classrooms or formal events.

An International Programme with Local Participation

Youth for Human Rights International was established in 2001 by educator Dr. Mary Shuttleworth, who grew up in South Africa during apartheid and became involved in educational efforts to increase awareness of fundamental freedoms.

The initiative subsequently developed into an international programme, with educational materials designed for use in a variety of cultural and community settings.

The Church of Scientology has supported the production and distribution of these resources, drawing on the interest in human rights expressed by Scientology founder L. Ron Hubbard.

In a 1969 essay, Hubbard referred to the Universal Declaration of Human Rights and argued for its implementation as a means of protecting individual freedoms and improving relations between governments and citizens.

That emphasis became part of the Church’s subsequent support for humanitarian and educational initiatives, including campaigns addressing human rights awareness, drug prevention and community betterment.

In Spain, the Church of Scientology has maintained a presence since the 1960s and opened its first church in 1980.

Through its Madrid congregation and associated volunteers in numerous other Spanish cities, the Church continues to support community-based educational activities, including the distribution of human rights materials.

The current initiative illustrates how an internationally developed educational programme can be applied at local level, reaching people in ordinary public spaces at a time when questions of dignity, social rights and democratic participation are prominent in public discussion.

About the Church of Scientology in Europe

Founded by L. Ron Hubbard, the Church of Scientology has churches, missions, affiliated groups and members throughout the European continent. Its communities support educational, preventive and humanitarian initiatives addressing human rights awareness, drug prevention, moral education and community betterment. Legal recognition of Scientology as a bona fide religion, and in certain jurisdictions as a charitable or public-benefit religious organisation, has developed through judicial and administrative decisions in several European countries. Its programmes emphasise education, prevention and voluntary participation in initiatives intended to benefit local communities.

Media Contact

Organization: European Office Church of Scientology for Public Affairs and Human Rights

Contact Person: Ivan Arjona

Website: https://www.scientologyeurope.org

Email: Send Email

Address: Boulevard de Waterloo 103

City: Brussels

State: Brussels

Country: Belgium

Release id: 50089

View source version on King Newswire:
Scientology Volunteers Bring Human Rights Education to Madrid Streets Amid Housing Debate

The structural model and refined targeting methodology, combined with a focused infill drill program, are giving Selkirk the data needed to advance Feasibility Study work in the next phase of restart development at the Minto Project.

Canada, 22nd Oct 2026 – Global Stocks News – Sponsored content disseminated on behalf of Selkirk Copper Mines. On October 15, 2026, Selkirk Copper Mines (TSXV: SCMI) (FRA: IO20) (OTCQX: SKRKF) announced additional results from the Phase 2 drill program at the Minto Project in Yukon, Canada. 

Sixteen months ago, Selkirk First Nation (SFN) purchased the former Minto Mine out of bankruptcy, then partnered with the Frank Giustra-backed Fiore Group to form Selkirk Copper Mines.

A September 2026 Preliminary Economic Assessment (PEA) outlines a 13-year mine life at 4,100 tonnes per day (tpd), starting with underground mining, then adding two open pits later in the mine life.

The structural model and refined targeting methodology, combined with a focused infill drill program, are giving Selkirk the data needed to advance Feasibility Study work in the next phase of restart development at the Minto Project. 

“These results, notably the high grade and thick intercepts at Minto North, Copper Keel, and Area 118, underpin our confidence in the continuity and grade within the zones of mineralization that will improve the quality of our updated mineral resource modeling,” stated Colin Joudrie, Selkirk President & CEO, in the October 15, 2026 press release.

“This increases the potential in our integrated mine planning efforts to deliver higher grade material to the mill, resulting in higher metal contained in concentrate. I look forward to continued positive results from the Phase 2 campaign over the next 8-10 weeks and another updated mineral resource estimate (MRE) in Q1 2027.” 

Above: Plan view of the Minto Mine Property showing surface projections of mineralized zones as well as Phase 1 and Phase 2 drill collars. Drill hole results presented in this release are highlighted.

2026 Phase 2 Drill Program

The Phase 2 drill program targeted 50,000 metres and focused on expansion, exploration, and infill drilling in key target areas. The geo team identified opportunities to complete additional metres while staying on schedule and on budget.

In the September 26, 2026 YouTube Crux Investor Interview below, Selkirk Copper CEO Colin Joudrie explains how a favourable PEA supports a fast-tracked restart plan for the Minto Project in the Yukon.

“We are Canada’s first publicly traded mining company with a majority equity interest held by a First Nation,” Joudrie told Crux Investor. “The Selkirk First Nation (SFN) own 18% of the company. They have put a great amount of trust in us. They want this mine to go into production. I’m comfortable that we are doing the right things, but I don’t want anyone to think it’s easy. We need to work at this key relationship, continually over the life of this operation and into the future.”

“We’ve been able to drill over 105,000 meters in the last 12 months on an asset that hasn’t seen a drill turn on it in four years. Selkirk Copper has a team of mine-builders that can get it done. The global copper market is short copper. It’s very short on the quality of copper concentrate we can produce, about 38% copper. That’s pretty rare.”

“We’re leveraging over $330 million of above-ground investment by prior operators,” continued Joudrie. “Our team is pleased with the results of the recent PEA. It has flagged things that we should improve on. That’s part of the study. But it’s given us full confidence that we can move forward with a 13-year mine life, which is the longest mine life this asset has ever had.”

“We’re happy with the PEA economics,” Scott Fulton, Selkirk VP of Engineering, confirmed to Guy Bennett, CEO of Global Stocks News (GSN). “Our engineers and mine planners have been working collaboratively throughout the PEA with a team of engineering consultants hired independently by The Selkirk First Nation.”

“This is a robust, complete and comprehensive review of all aspects of the mine design, processing plant and infrastructure engineering,” added Fulton. “All costs have been built up from first principles over the Capex, Opex and Susex periods. Certain pre-capex costs are not included in the PEA economic model. We estimate these costs to be about $20 million.”

Because of key operational and financial variables, the SCMI PEA baseline economics are conservative.  For instance, the headline Net Present Value (NPV) number (C$494 million) is based on a copper “planning price” of $5.00/lb.

At the current copper price of US$6.50/lb, the after-tax NPV more than doubles to C$1.023 billion. Consensus copper price projections indicate a long-term upward trend, driven by green energy electrification, AI data centre demand and mine-supply deficits. A hypothetical $1/lb increase to $7.50/lb adds another $362 million to the projected NPV.

“The PEA confirms that we have a pathway to put the Minto Mine back into production, with a low capital expenditure (capex),” added Fulton. “A 13-year mine plan is a good start. There is potential to the north and south of the Minto Mine that I believe could turn this into a multi-decade project.”

Note: readers are cautioned that the PEA is preliminary in nature and includes Inferred Mineral Resources that are considered too speculative geologically to have economic considerations applied that would enable these resources to be categorized as Mineral Reserves. There is no certainty that the projections in the PEA will be realized. Mineral Resources which are not Mineral Reserves do not have demonstrated economic viability.

As of October 14, 2026, 54,711 metres of drilling have been completed in 223 drill holes, representing 109% of the planned meterage. The drill program is nearing completion. All geological logging, core cutting, and sample shipping are expected to be complete by early November.

Technical aspects of this release have been reviewed, verified and approved by Leif Bailey, P.Geo., Director of Geoscience & Exploration of Selkirk Copper Mines Inc., who is a qualified person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects. 

Disclaimer: Selkirk Copper Mines paid GSN C$1,750 for the research, creation and dissemination of this content.

Contact: guy.bennett@globalstocksnews.com

Full Disclaimer: Global Stocks News (GSN) researches and fact-checks diligently, but we cannot ensure our publications are free from error. Investing in publicly traded stocks is speculative and carries a high degree of risk. GSN makes no recommendation to purchase any individual stock. There may be forward-looking statements such as “project,” “anticipate,” “expect,” which are based on reasonable expectations, but these statements are imperfect predictors of future events. When compensation has been paid to GSN, the amount and nature of the compensation will be disclosed clearly.

Media Contact

Organization: Global Stocks News

Contact Person: guy.bennett@globalstocksnews.com

Website: https://www.globalstocksnews.com

Email: Send Email

Country: Canada

Release id: 50083

View source version on King Newswire:
Selkirk Copper Phase 2 Drill Program Returns High-Grade Intercepts At Minto North, Copper Keel, and Area 118

A reusable, medical-grade silicone treatment tool designed to help optimize topical skincare performance around the eyes and smile lines

United States, 22nd Oct 2026 – TOPICAL SKIN, a leader in clean dermaceutical skincare, announces the launch of its Eye & Smile Reusable Silicone Patches Expression Line HydraLock. Designed for the areas most affected by daily facial movement, these reusable silicone patches help lock in topical treatments, support epidermal hydration, and visibly smooth the look of fine lines and creasing over time.

Made from soft, flexible, medical-grade silicone, the HydraLock patches comfortably hug the periorbital and perioral areas—including the under-eye region and smile or laugh lines. When applied over an appropriate serum or cream, the patches create a moisture-sealing, occlusive barrier that helps minimize moisture loss and supports prolonged contact between the skin and the user’s chosen treatment product.
The result is a simple yet elevated way to help enhance the performance of existing skincare while addressing the visible impact of dehydration, repetitive facial expressions, and mechanical compression in areas prone to early creasing.

“Some of the most visible expression lines occur in areas where the skin is constantly moving, folding, and experiencing repeated mechanical stress,” said Ewelina Aiossa, Founder of TOPICAL SKIN. “The Expression Line HydraLock patches were developed as a reusable skincare tool that works alongside the formulas consumers already love—helping create a more hydrated, smoother-looking appearance in precisely targeted zones.”
Unlike disposable under-eye masks and single-use treatment patches, Eye + Smile Reusable Silicone Patches are designed for repeated use, offering a more sustainable addition to a skincare routine without requiring consumers to replace their favorite targeted eye or line treatments.

Designed to Enhance Every Routine
Expression Line HydraLock patches are intended to be used with compatible eye creams, serums, moisturizers, or targeted treatments. By helping create an occlusive environment, the patches support epidermal hydration and can help improve the visible smoothness of the skin’s surface with consistent use.

Key benefits include:
    ● Helps reduce the appearance of fine lines and creasing around the eyes and smile area with consistent use.
    ● Helps visibly improve skin smoothness and hydration in targeted areas when used with an appropriate topical treatment.
    ● Creates a moisture-sealing barrier designed to enhance the effectiveness of serums and creams.
    ● Targets the under-eye area, smile lines, laugh lines, and nasolabial folds—zones commonly affected by repetitive expression and facial movement.
    ● Made with soft, flexible medical-grade silicone for a comfortable, contour-hugging fit.
    ● Reusable design helps replace dozens of single-use masks and patches.

The launch reflects TOPICAL SKIN’s continued commitment to practical, science-led skincare solutions that connect skin biology, ingredient performance, and everyday consumer use. Rather than positioning a patch as a replacement for skincare, HydraLock patches are designed to complement and amplify the user’s existing regimen.

How to Use
Apply a thin, even layer of a preferred serum, eye cream, moisturizer, or targeted treatment to clean skin. Place the patches over the under-eye and/or smile-line area, allowing the silicone to conform to the contours of the face. After use, gently remove, cleanse according to care instructions, and store for reuse. Eye + Smile Reusable Silicone Patches Expression Line HydraLock are now available at topicalskin.com.

About TOPICAL SKIN
TOPICAL SKIN is a science-focused skincare brand dedicated to creating high-performance, thoughtfully developed solutions for visible skin concerns. Rooted in a modern understanding of formulation, skin biology, and daily skin needs, the brand develops targeted products and tools designed to help consumers achieve healthier-looking, more resilient, and more radiant skin. TOPICAL SKIN’s ethos is grounded in cruelty-free, dermatologist-endorsed formulations designed for efficacy and sensorial enjoyment.

TOPICAL SKIN is available at topicalskin.com and through select professional and specialty retail partners across the United States, including dermatology clinics, plastic surgery offices, medical spas, and apothecaries. The brand is also available online at Ulta.com (https://www.ulta.com/brand/topical-skin), Nordstrom.com (https://www.nordstrom.com/brands/topical-skin–81036410), Macys.com (https://www.macys.com/shop/brands/topical-skin?id=406772), and other select retailers.

Media Contact

Organization: TOPICAL SKIN

Contact Person: Colleen Mathis Public Relations

Website: https://topicalskin.com/

Email: Send Email

Country: United States

Release id: 50088

View source version on King Newswire:
TOPICAL SKIN Clean Dermaceutical Brand Launches Medical-Grade Eye Smile Reusable Silicone Patches

Hannover, Germany, October 21st, 2026, FinanceWire

Italian-built NexCut helps sheet metal shops tell a settings problem from a machine fault, and gives newer operators a guided way to learn what veterans know.

NexFabric today presented NexCut in Europe for the first time, at EuroBLECH 2026 on the stand of Esautomotion (Euronext Growth Milan: ESAU), Hall 15, Stand E28, after a first showing at CIIF in Shanghai. NexCut is the first laser-cutting application of the NexFabric industrial AI platform. Built in Italy, it pairs AI-assisted analysis with checks the operator confirms, so manufacturing teams can diagnose production problems without handing the decision to the machine.

Factories are losing the people who know their machines best. In Germany, 12.9 million workers, close to 30% of the workforce, will reach retirement age by 2036, according to the Federal Statistical Office. In Italy, companies reported difficulty filling 47.8% of planned hires, with CNC operators and welders among the hardest roles to fill, according to a CGIA analysis of Unioncamere Excelsior data. NexCut is built for that handover. A junior operator learns the diagnostic routine on the job, guided step by step, instead of spending years picking it up beside a veteran. Every diagnosis is saved as a procedure the next shift can reuse.

NexCut addresses a practical challenge in laser cutting: telling a problem with process settings from an issue with the machine or its hardware. Take a common case. Dross starts building on the underside of the parts. A less experienced operator may slow the cut or raise gas pressure. If the real cause is a dirty lens or a worn nozzle, that change wastes material and the fault stays. NexCut has the operator check the hardware first and confirm what they find. If there’s a hardware problem, it won’t clear the machine to run until it’s fixed.

Here’s how it works. Each laser cutter gets its own NexCut kit: a touchscreen operator station at the machine and a connected hardware module that brings in process signals from the cutter. When cut quality drops, NexCut combines those signals with physical checks the operator carries out and confirms, covering the lens, gas, focus position, cutting height, nozzle and machine stability. It narrows down the likely cause, explains why, and points to the fix. The operator makes the call. Every step is logged, so the process stays traceable and repeatable, and a central dashboard gives production managers a view across all connected machines.

“Running a laser cutter well takes years of experience, and even experienced operators still make mistakes,” said Stefano D’Andria, CEO & Founder of NexFabric. “NexCut is there to help and teach. Any operator can use it, whatever their experience, and the decision always stays with the person at the machine.”

The first proof of concept is running under real operating conditions at Soluzioni Markaurelio S.r.l. in Avezzano, Italy. It is testing NexCut against clear targets: an average guided diagnosis of 7 to 11 minutes, a 50 to 70% reduction in setup time, startup scrap and machine stoppages, and new operators working on their own within two to four weeks.

NexCut is built for manufacturers across Europe that run laser cutters. Operators get step-by-step guidance at the machine. Owners keep the know-how in-house when experienced staff leave. NexFabric plans to work with multiple industrial partners and dealers, broadening access while preserving manufacturer choice.

“Industrial AI must increase human decision-making capability, not replace it,” D’Andria added. “We’re starting in Italy, where our R&D is, and building for factories across Europe.”

D’Andria is at EuroBLECH through October 23 and available for interviews at the stand. To book a time, contact Orian Tal at orian@thepitch.media.

Manufacturers, dealers and technology partners can learn more at https://nexcut.ai or contact info@nexfabric.ai.

About NexFabric

NexFabric is an industrial AI platform built in Italy. It connects manufacturing processes and human expertise through guided diagnosis and human verification. Its first application, NexCut, focuses on laser cutting. Learn more at https://nexfabric.ai.

Contact

Orian Tal
The Pitch
orian@thepitch.media

Hannover, Germany, October 21st, 2026, FinanceWire

Italian-built NexCut helps sheet metal shops tell a settings problem from a machine fault, and gives newer operators a guided way to learn what veterans know.

NexFabric today presented NexCut in Europe for the first time, at EuroBLECH 2026 on the stand of Esautomotion (Euronext Growth Milan: ESAU), Hall 15, Stand E28, after a first showing at CIIF in Shanghai. NexCut is the first laser-cutting application of the NexFabric industrial AI platform. Built in Italy, it pairs AI-assisted analysis with checks the operator confirms, so manufacturing teams can diagnose production problems without handing the decision to the machine.

Factories are losing the people who know their machines best. In Germany, 12.9 million workers, close to 30% of the workforce, will reach retirement age by 2036, according to the Federal Statistical Office. In Italy, companies reported difficulty filling 47.8% of planned hires, with CNC operators and welders among the hardest roles to fill, according to a CGIA analysis of Unioncamere Excelsior data. NexCut is built for that handover. A junior operator learns the diagnostic routine on the job, guided step by step, instead of spending years picking it up beside a veteran. Every diagnosis is saved as a procedure the next shift can reuse.

NexCut addresses a practical challenge in laser cutting: telling a problem with process settings from an issue with the machine or its hardware. Take a common case. Dross starts building on the underside of the parts. A less experienced operator may slow the cut or raise gas pressure. If the real cause is a dirty lens or a worn nozzle, that change wastes material and the fault stays. NexCut has the operator check the hardware first and confirm what they find. If there’s a hardware problem, it won’t clear the machine to run until it’s fixed.

Here’s how it works. Each laser cutter gets its own NexCut kit: a touchscreen operator station at the machine and a connected hardware module that brings in process signals from the cutter. When cut quality drops, NexCut combines those signals with physical checks the operator carries out and confirms, covering the lens, gas, focus position, cutting height, nozzle and machine stability. It narrows down the likely cause, explains why, and points to the fix. The operator makes the call. Every step is logged, so the process stays traceable and repeatable, and a central dashboard gives production managers a view across all connected machines.

“Running a laser cutter well takes years of experience, and even experienced operators still make mistakes,” said Stefano D’Andria, CEO & Founder of NexFabric. “NexCut is there to help and teach. Any operator can use it, whatever their experience, and the decision always stays with the person at the machine.”

The first proof of concept is running under real operating conditions at Soluzioni Markaurelio S.r.l. in Avezzano, Italy. It is testing NexCut against clear targets: an average guided diagnosis of 7 to 11 minutes, a 50 to 70% reduction in setup time, startup scrap and machine stoppages, and new operators working on their own within two to four weeks.

NexCut is built for manufacturers across Europe that run laser cutters. Operators get step-by-step guidance at the machine. Owners keep the know-how in-house when experienced staff leave. NexFabric plans to work with multiple industrial partners and dealers, broadening access while preserving manufacturer choice.

“Industrial AI must increase human decision-making capability, not replace it,” D’Andria added. “We’re starting in Italy, where our R&D is, and building for factories across Europe.”

D’Andria is at EuroBLECH through October 23 and available for interviews at the stand. To book a time, contact Orian Tal at orian@thepitch.media.

Manufacturers, dealers and technology partners can learn more at https://nexcut.ai or contact info@nexfabric.ai.

About NexFabric

NexFabric is an industrial AI platform built in Italy. It connects manufacturing processes and human expertise through guided diagnosis and human verification. Its first application, NexCut, focuses on laser cutting. Learn more at https://nexfabric.ai.

Contact

Orian Tal
The Pitch
orian@thepitch.media

Boca Raton, Florida, October 21st, 2026, FinanceWire

• Final pre-MAA package submitted to MHRA on October 20, 2026
• Full MAA submission targeted for early February 2027, under a revised strategy that could bring potential UK approval forward by approximately six weeks
• US BLA expected to be submitted in Q2, 2027

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has submitted its final pre-Marketing Authorisation Application (pre-MAA) package to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Ebstrocel (CORDStrom), its investigational cell therapy for recessive dystrophic epidermolysis bullosa (RDEB). The company has revised prior guidance to indicate that faster-than-expected manufacturing progress supports a full MAA submission in early February 2027, with potential UK approval in mid-2027, subject to MHRA review.

Following MHRA feedback on the final pre-MAA package, INmune Bio plans to finalize and submit a complete application in February, 2027, replacing the sequential rolling submission previously planned to begin in late 2026. Based on progress in chemistry, manufacturing and controls (CMC) and discussions with regulatory advisors, the Company believes this approach could accelerate potential UK approval by approximately six weeks from prior guidance.

The Company anticipates an MHRA response within three to six months after submission, subject to application validation, agency review and any requests for additional information. Submission of the complete package is intended to support assessment of the clinical, manufacturing and quality data together.

“This is a remarkable achievement by the whole CMC team and our external regulatory advisors allowing us to accelerate the potential approval for Ebstrocel for children with RDEB,” said Mark Lowdell, Chief Scientific Officer of INmune Bio. “Our progress allows us to bring forward the anticipated timeline to commercial supply, subject to approval, for children and families waiting for treatment.”

In parallel, INmune Bio has engaged U.S. regulatory advisors with rare disease expertise to prepare and submit a Type B meeting request to the U.S. Food and Drug Administration (FDA). Subject to feedback from that meeting, the Company plans to submit a Biologics License Application (BLA) in the second quarter of 2027, seeking traditional or accelerated approval, as appropriate.

“Based on positive feedback from our regulatory consultants in the U.S, we are prioritizing our FDA application ahead of an EMA submission, building on Ebstrocel’s U.S. Orphan Drug and Rare Pediatric Disease designations,” said David Moss, Chief Executive Officer of INmune Bio. “With potential UK and U.S. approvals in 2027, we are approaching a pivotal year. Approval in either or both markets would mark a major milestone for INmune Bio and bring Ebstrocel closer to patients and families living with RDEB.”

About INmune Bio Inc.

INmune Bio Inc. is a publicly traded (NASDAQ: INMB), late-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. The Company’s clinical-development strategy centers on advanced precision medicine, matching drug mechanisms directly to patient biology to optimize clinical outcomes.

INmune Bio is actively advancing two late-stage product platforms toward registrational milestones:

• CORDStrom: A proprietary, pooled, allogeneic, human umbilical cord-derived mesenchymal stromal cell platform engineered to address the historical clinical challenges of donor variability and manufacturing inconsistency. Following successful clinical readouts in RDEB, the platform is transitioning to regulatory filing phases, with an MAA planned for the UK MHRA in 2026 and EU EMA in 2027, alongside a planned U.S. Biologics License Application (BLA) submission.
• XPro1595: A Dominant-Negative Tumor Necrosis Factor (DN-TNF) platform designed to selectively neutralize soluble TNF (sTNF) and reduce neuroinflammation without compromising protective immune function. Backed by recently granted FDA Fast Track designation and successful regulatory alignment from an End-of-Phase 2 meeting, XPro1595 is positioned for an integrated Phase 2b/3 seamless adaptive registrational program in neuroinflammation-enriched early Alzheimer’s disease.

To learn more about INmune Bio’s pipeline and its approach to harnessing the innate immune system, please visit www.inmunebio.com.

Forward Looking Statements

The Company’s product candidates remain in clinical development stage and there is no assurance that any specific outcome will be achieved. Any statements contained in this press release related to the development or commercialization of product candidates and other business and financial matters, including without limitation, trial results and data, including Ebstrocel, XPro and INKmune trial results, timing of key milestones, future plans or expectations, and the prospects for receiving regulatory approval or commercializing or selling any product or drug candidates, may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations but are subject to several risks and uncertainties. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements because of these risks and uncertainties. CORDStrom, XPro1595 (XPro, pegipanermin), and INKmune have either finished clinical trials, are still in clinical trials or are preparing to start clinical trials and have not been approved by the US Food and Drug Administration (FDA), the UK MHRA or any regulatory body and there cannot be any assurance that they will be approved by the FDA, the UK MHRA or any regulatory body or that any specific results will be achieved. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to produce more drug for clinical trials; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, the Company’s Quarterly Reports on Form 10-Q and the Company’s Current Reports on Form 8-K. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.

INmune Bio Contacts:

David Moss

Chief Executive Officer

(561) 710-0512

info@inmunebio.com

Contact

Head of Investor Relations
Daniel Carlson
dcarlson@inmunebio.com
(415) 509-4590